Top Markets
Coin of the day
Theralase Technologies Inc. Theralase Technologies Inc.

Theralase Technologies Inc.

TLT
Rank in Stocks #26766
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette GuΓ©rin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Share Price
$0.13210864
Market Cap
$39.06M
Change (1 day)
2.86%
Change (1 year)
-16.69%
Country
CA
Trade Theralase Technologies Inc. (TLT)

Category

Stock price history for Theralase Technologies Inc. (TLT)
Highest end of day price: $0.14 on 2026-08-01

Lowest end of day price: $0.43 on 2008-02-01
Stock price history of Theralase Technologies Inc. from 2008 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 54.92%
2025 -37.63%
2024 36.48%
2023 -45.01%
2022 -6.28%
2021 64.88%
2020 -29.76%
2019 -7.60%
2018 21.91%
2017 -3.00%
2016 -24.70%
2015 -39.48%
2014 21.31%
2013 106.96%
2012 -56.21%
2011 -34.50%
2010 56.25%
2009 679.18%
2008 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$114.46 -13.58%
US
$337.66 -13.83%
US
$93.50 0.30%
IE
$50.36 -52.52%
US
$47.28 -15.75%
DE